Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 1.000 | None | 0.974 | 0 | 0 | 2000 | 2019 | |||||||||
|
retinoic acid induced 1 | 0.545 | 0.731 | 1.00 |
|
disease | 1.000 | definitive | 0.981 | 0 | 0 | 2001 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 1.000 | strong | 0.965 | 0 | 0 | 1992 | 2019 | ||||||||
|
solute carrier family 7 member 9 | 0.666 | 0.692 | 9.1E-10 |
|
disease | 1.000 | definitive | 1.000 | 0 | 0 | 1999 | 2018 | ||||||||
|
C1q and TNF related 5 | 0.663 | 0.346 | 0.84 |
|
disease | 1.000 | None | 1.000 | 0 | 0 | 2003 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 1.000 | None | 0.967 | 0 | 0 | 1983 | 2020 | ||||||||
|
EGF containing fibulin extracellular matrix protein 1 | 0.540 | 0.769 | 1.00 |
|
disease | 1.000 | limited | 0.947 | 0 | 0 | 1999 | 2018 | ||||||||
|
FMRP translational regulator 1 | 0.473 | 0.769 | 0.65 |
|
disease | 1.000 | definitive | 0.985 | 0 | 0 | 1991 | 2020 | ||||||||
|
ATP binding cassette subfamily A member 4 | 0.493 | 0.769 | 5.3E-48 |
|
phenotype | 1.000 | limited | 0.995 | 0 | 0 | 1997 | 2020 | ||||||||
|
ATP binding cassette subfamily A member 4 | 0.493 | 0.769 | 5.3E-48 |
|
disease | 1.000 | None | 0.978 | 0 | 0 | 1997 | 2020 | ||||||||
|
glucokinase | 0.523 | 0.808 | 0.63 |
|
disease | 1.000 | strong | 1.000 | 0 | 0 | 1992 | 2019 | ||||||||
|
GNAS complex locus | 0.420 | 0.885 | 0.68 |
|
disease | 1.000 | strong | 1.000 | 0 | 0 | 1998 | 2018 | ||||||||
|
cytochrome P450 family 4 subfamily V member 2 | 0.670 | 0.577 | 2.2E-10 |
|
disease | 1.000 | None | 0.976 | 0 | 0 | 2004 | 2019 | ||||||||
|
guanylate cyclase 2D, retinal | 0.570 | 0.769 | 6.5E-10 |
|
disease | 1.000 | None | 0.984 | 0 | 0 | 1995 | 2020 | ||||||||
|
huntingtin | 0.548 | 0.654 | 1.00 |
|
disease | 1.000 | limited | 0.987 | 0 | 0 | 1993 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 1.000 | None | 0.966 | 0 | 0 | 1970 | 2019 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 1.000 | limited | 0.982 | 0 | 0 | 1992 | 2020 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 1.000 | None | 0.968 | 0 | 0 | 2005 | 2020 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
group | 1.000 | definitive | 0.951 | 0 | 0 | 1995 | 2020 | ||||||||
|
melanocortin 4 receptor | 0.535 | 0.692 | 9.2E-04 |
|
disease | 1.000 | None | 0.961 | 0 | 0 | 1997 | 2020 | ||||||||
|
myelin protein zero | 0.503 | 0.846 | 0.27 |
|
disease | 1.000 | None | 1.000 | 0 | 0 | 1992 | 2019 | ||||||||
|
myelin protein zero | 0.503 | 0.846 | 0.27 |
|
disease | 1.000 | None | 1.000 | 0 | 0 | 1992 | 2019 | ||||||||
|
serpin family C member 1 | 0.507 | 0.769 | 1.00 |
|
disease | 1.000 | strong | 0.987 | 0 | 0 | 1984 | 2019 | ||||||||
|
myosin heavy chain 9 | 0.505 | 0.808 | 1.00 |
|
disease | 1.000 | definitive | 0.984 | 0 | 0 | 1998 | 2019 | ||||||||
|
ornithine aminotransferase | 0.593 | 0.731 | 7.7E-07 |
|
disease | 1.000 | definitive | 0.962 | 0 | 0 | 1981 | 2019 |